Literature DB >> 19632985

New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domain.

Laure Dumoutier1, Carole de Meester, Jan Tavernier, Jean-Christophe Renauld.   

Abstract

Activation of STAT proteins by cytokines is initiated by their Src homology 2 domain-mediated association with phosphotyrosine residues from the cytoplasmic domain of a receptor. Here, we show that the C terminus of the interleukin-22 receptor (IL-22R) recruits in a tyrosine-independent manner the coiled-coil domain of STAT3. Mutation of all IL-22R cytoplasmic tyrosines did not abolish activation of STAT3, in contrast to that of STAT1 and STAT5. Coimmunoprecipitation and glutathione S-transferase pulldown experiments showed that the coiled-coil domain of STAT3 is constitutively associated with the C-terminal part of IL-22R, and a chimeric STAT3-STAT5 protein containing the coiled-coil domain of STAT3 could be activated by this tyrosine-independent mechanism. Deletion of the C-terminal part of IL-22R dramatically decreased its ability to activate STAT3 and to mediate IL-22 activity in cell lines, demonstrating that preassociation of STAT3 with this cytokine receptor, independent from the interaction between the Src homology 2 domain and phosphotyrosines, is required for its full activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19632985      PMCID: PMC2785325          DOI: 10.1074/jbc.M109.007955

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Three-dimensional structure of the Stat3beta homodimer bound to DNA.

Authors:  S Becker; B Groner; C W Müller
Journal:  Nature       Date:  1998-07-09       Impact factor: 49.962

2.  Functional and biochemical characterization of mouse P40/IL-9 receptors.

Authors:  C Druez; P Coulie; C Uyttenhove; J Van Snick
Journal:  J Immunol       Date:  1990-10-15       Impact factor: 5.422

3.  An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.

Authors:  Y Fujitani; M Hibi; T Fukada; M Takahashi-Tezuka; H Yoshida; T Yamaguchi; K Sugiyama; Y Yamanaka; K Nakajima; T Hirano
Journal:  Oncogene       Date:  1997-02-20       Impact factor: 9.867

4.  A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9.

Authors:  J B Demoulin; C Uyttenhove; E Van Roost; B DeLestré; D Donckers; J Van Snick; J C Renauld
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

5.  Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling.

Authors:  X Li; S Leung; I M Kerr; G R Stark
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

6.  Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors.

Authors:  N Stahl; T J Farruggella; T G Boulton; Z Zhong; J E Darnell; G D Yancopoulos
Journal:  Science       Date:  1995-03-03       Impact factor: 47.728

Review 7.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

8.  Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor.

Authors:  A Sotiropoulos; S Moutoussamy; F Renaudie; M Clauss; C Kayser; F Gouilleux; P A Kelly; J Finidori
Journal:  Mol Endocrinol       Date:  1996-08

9.  Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein.

Authors:  H Yan; K Krishnan; A C Greenlund; S Gupta; J T Lim; R D Schreiber; C W Schindler; J J Krolewski
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

10.  IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not.

Authors:  Kerstin Wolk; Harald S Haugen; Wenfeng Xu; Ellen Witte; Kim Waggie; Monica Anderson; Elmar Vom Baur; Katrin Witte; Katarzyna Warszawska; Sandra Philipp; Caroline Johnson-Leger; Hans-Dieter Volk; Wolfram Sterry; Robert Sabat
Journal:  J Mol Med (Berl)       Date:  2009-03-30       Impact factor: 4.599

View more
  32 in total

Review 1.  Structure and function of interleukin-22 and other members of the interleukin-10 family.

Authors:  Daniela Barretto Barbosa Trivella; José Ribamar Ferreira-Júnior; Laure Dumoutier; Jean-Christophe Renauld; Igor Polikarpov
Journal:  Cell Mol Life Sci       Date:  2010-05-08       Impact factor: 9.261

Review 2.  Role of interleukin-22 in inflammatory bowel disease.

Authors:  Lin-Jing Li; Chen Gong; Mei-Hua Zhao; Bai-Sui Feng
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

3.  Association of Shp2 with phosphorylated IL-22R1 is required for interleukin-22-induced MAP kinase activation.

Authors:  Songshu Meng; Qiu Gui; Qing Xu; Kaixin Lu; Xinan Jiao; Jian Fan; Baoxue Ge; Yuehai Ke; Shengping Zhang; Jie Wu; Chuangui Wang
Journal:  J Mol Cell Biol       Date:  2010-08       Impact factor: 6.216

4.  IL-22 promotes the proliferation of cancer cells in smoking colorectal cancer patients.

Authors:  Bao Song; Yuan Ma; Xiuchun Liu; Wanhu Li; Jianbo Zhang; Jie Liu; Jinxiang Han
Journal:  Tumour Biol       Date:  2015-08-22

5.  Synthetic interleukin 22 (IL-22) signaling reveals biological activity of homodimeric IL-10 receptor 2 and functional cross-talk with the IL-6 receptor gp130.

Authors:  Sofie Mossner; Marcus Kuchner; Nastaran Fazel Modares; Birgit Knebel; Hadi Al-Hasani; Doreen M Floss; Jürgen Scheller
Journal:  J Biol Chem       Date:  2020-07-01       Impact factor: 5.157

6.  E3 ubiquitin ligase NKLAM ubiquitinates STAT1 and positively regulates STAT1-mediated transcriptional activity.

Authors:  Donald W Lawrence; Jacki Kornbluth
Journal:  Cell Signal       Date:  2016-08-26       Impact factor: 4.315

Review 7.  Emerging role of interleukin-22 in autoimmune diseases.

Authors:  Hai-Feng Pan; Xiang-Pei Li; Song Guo Zheng; Dong-Qing Ye
Journal:  Cytokine Growth Factor Rev       Date:  2012-08-18       Impact factor: 7.638

8.  Identification of canonical tyrosine-dependent and non-canonical tyrosine-independent STAT3 activation sites in the intracellular domain of the interleukin 23 receptor.

Authors:  Doreen M Floss; Simone Mrotzek; Tobias Klöcker; Jutta Schröder; Joachim Grötzinger; Stefan Rose-John; Jürgen Scheller
Journal:  J Biol Chem       Date:  2013-05-14       Impact factor: 5.157

9.  Acute infection of mice with Clostridium difficile leads to eIF2α phosphorylation and pro-survival signalling as part of the mucosal inflammatory response.

Authors:  Amir A Sadighi Akha; Casey M Theriot; John R Erb-Downward; Andrew J McDermott; Nicole R Falkowski; Heather M Tyra; D Thomas Rutkowski; Vincent B Young; Gary B Huffnagle
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

Review 10.  IL-22: a promising candidate to inhibit viral-induced liver disease progression and hepatocellular carcinoma.

Authors:  Muhammad Saalim; Saleha Resham; Sobia Manzoor; Hassam Ahmad; Shahla Jaleel; Javed Ashraf; Muhammad Imran; Sidrah Naseem
Journal:  Tumour Biol       Date:  2015-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.